9MW0813

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 9MW0813, covering 2022-04-12 to 2022-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema [Phase 3]